Supplemental material
Bioengineered
Volume 13, 2022 - Issue 2
Open access
1,931
Views
6
CrossRef citations to date
0
Altmetric
Research Paper
tRF-19-W4PU732S promotes breast cancer cell malignant activity by targeting inhibition of RPL27A (ribosomal protein-L27A)
Zhengxiang Zhanga Department of Oncology, Yijishan Hospital, First Affiliated Hospital of Wannan Medical College, Wuhu, ChinaView further author information
, Zhiping Liub Department of Gastrointestinal Surgery, The Affiliated Hefei Hospital of Anhui Medical University, Hefei, ChinaView further author information
, WeiDong Zhaoa Department of Oncology, Yijishan Hospital, First Affiliated Hospital of Wannan Medical College, Wuhu, ChinaView further author information
, Xiaohan Zhaoa Department of Oncology, Yijishan Hospital, First Affiliated Hospital of Wannan Medical College, Wuhu, ChinaView further author information
& Yunxiang Taoc Department of Dermatology, Yijishan Hospital, First Affiliated Hospital of Wannan Medical College, Wuhu, ChinaCorrespondence[email protected]
https://orcid.org/0000-0001-8006-7341View further author information
Pages 2087-2098
|
Received 23 Sep 2021, Accepted 23 Dec 2021, Published online: 14 Jan 2022
Related Research Data
tRF-19-W4PU732S promotes breast cancer cell malignant activity by targeting inhibition of RPL27A (ribosomal protein-L27A)
Source:
Taylor & Francis
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.